Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
Holding BNR?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-$1.58Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Dec 04, 2024
|% Change Since: 7.87%
|Next Earnings Date:Mar 26, 2025
Earnings Call Sentiment|Positive
The earnings call presented a positive financial turnaround with significant improvements in sales efficiency, profitability, and in-hospital revenue growth. Despite industry challenges, the company demonstrated a strong cash position and strategic adaptability.Company Guidance
During Burning Rock's Q1 2024 earnings call, the company provided optimistic guidance, highlighting significant improvements in their financial metrics. The sales and marketing expenses were reduced to 35% of revenue, marking a historic efficiency level, which underpins their operating profitability. The company's gross profit minus SG&A expenses turned positive again in Q1 2024, after a challenging Q3 and Q4 in 2023. Burning Rock ended the quarter with an RMB 573 million cash balance and projected a cash outflow between RMB 150 million to RMB 200 million for 2024. They also noted a successful transition in their revenue model, with more income now coming from in-hospital services than from Central Labs, contributing to a 4% increase in overall revenue quarter-over-quarter. The company aims to maintain positive non-GAAP gross profit minus SG&A for the entirety of 2024 and anticipates further cash flow improvements into 2025.Record Low Sales and Marketing Expenses
Achieved sales and marketing expenses as a percentage of revenue at 35%, marking a historic low and the most efficient quarter in recent operating history.
Positive Financial Turnaround
Turned profitable again in Q1 2024 after challenges in Q3 and Q4 of 2023, with a focus on making the company cash flow positive in the future.
In-Hospital Revenue Growth
First quarter where revenue from in-hospital surpassed Central Lab, with overall revenue up 4% quarter-over-quarter, driven by in-hospital growth.
Strong Cash Position
Ended the quarter with RMB 573 million cash balance and a reduced cash outflow, providing a good 3-year cash runway without the need for capital raising.
---
BNR Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BNR Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Dec 04, 2024 | $6.10 | $6.93 | +13.61% |
| Aug 23, 2024 | $6.44 | $6.00 | -6.83% |
| May 29, 2024 | $7.55 | $7.55 | 0.00% |
| Mar 28, 2024 | $7.28 | $7.00 | -3.85% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Burning Rock Biotech Ltd. (BNR) report earnings?
Burning Rock Biotech Ltd. (BNR) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Burning Rock Biotech Ltd. (BNR) earnings time?
Burning Rock Biotech Ltd. (BNR) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BNR EPS forecast?
Currently, no data Available
---